When tirzepatide is exposed to freezing temperatures, irreversible physical and chemical changes occur that compromise the medication's safety and effectiveness
Without proprietary stability data, the default BUD for a refrigerated sterile preparation is typically 28 days
It is specifically for individuals with a starting body mass index (BMI) of 30 kg/m2 or higher (classified as obese) or 27 kg/m2 or higher (classified as overweight) with at least one weight-related medical condition, such as heart disease, elevated cholesterol, high blood pressure, type 2 diabetes, or sleep apnea
Reply STOP to opt-out at any time
Currently, injectable semaglutide, marketed as Wegovy is available for weight loss and chronic weight management
Tirzepatide is the worlds first dual GIP/GLP-1 receptor agonist